Close menu




April 22nd, 2025 | 07:10 CEST

TSMC, NetraMark, and Siemens Energy defy the crisis

  • AI
  • Biotechnology
  • Energy
  • semiconductor
Photo credits: pixabay.com

The global economy is faltering. The US president's tariff policy prompted the World Trade Organization (WTO) to drastically cut its forecast for global trade in its latest report. It drastically cut its forecast for global trade in goods and now expects global trade volume to decline by 0.2% in 2025. Several analysts have also lowered their outlook for the S&P 500. While experts' price targets at the beginning of the year were still at 6,600 points, they have now been lowered to an average of 5,950 points. Nevertheless, some companies are able to weather the crisis and at least confirm their annual targets.

time to read: 4 minutes | Author: Stefan Feulner
ISIN: TAIWAN SEMICON.MANU.ADR/5 | US8740391003 , NETRAMARK HOLDINGS INC | CA64119M1059 , SIEMENS ENERGY AG NA O.N. | DE000ENER6Y0

Table of contents:


    Taiwan Semiconductor – In the eye of the storm

    The Trump earthquake naturally also affected the shares of the world's largest independent semiconductor manufacturer. Since its high of USD 226.40 at the end of January, the share price has lost almost 33% to USD 151.82. Looking at the chart, it is still too early to sound the all-clear. If the double low marked in August last year and on April 7, 2025, is broken again, further sell-offs are likely. The next support level would then be in the USD 125 range.

    From a fundamental perspective, however, the Taiwanese giant posted impressive first-quarter figures. TSMC's net profit rose by 60% to around USD 11.1 billion in the most recent quarter. Revenue also increased significantly by 41.6% to USD 25.80 billion, exceeding analysts' expectations. The Company expects further growth in the second quarter, signaling to the markets that the AI boom is continuing. After all, chips with advanced structure widths (7 nm and smaller) now account for 73% of wafer sales.

    Despite growing trade tensions with the US, the world's largest contract manufacturer for semiconductors is sticking to its ambitious outlook for the 2025 fiscal year. The Company expects revenue growth "of around 20%", as CEO C.C. Wei confirmed – precisely in line with the January forecast. Planned investments also remain unchanged at USD 38 to 42 billion.

    The Company's CEO also rejected speculation about a possible collaboration with Intel. He made it clear to analysts that "TSMC is not in discussions with any other company regarding joint ventures, technology licensing, or technology exchange." Therefore, media reports about a joint project to support Intel's struggling foundry business are completely unfounded.

    NetraMark – Strong momentum

    While many AI companies are currently undergoing a correction, with Nvidia, for example, losing around 35% of its value since its all-time high on January 7, 2025, NetraMark shares are standing firm. After a brief, volatile correction to the CAD 1 range, the share was bought up amid rising sales and is currently trading at CAD 1.62, just below its all-time high of CAD 1.79. A break above this significant mark would generate a strong buy signal, which should push the price above the CAD 2 mark.

    The vision of the CAD 130 million company is huge. The Canadian company wants nothing less than to revolutionize clinical trials in the pharmaceutical industry with the help of modern data analysis and the use of artificial intelligence. Given the inefficiency that currently prevails in the pharmaceutical industry, the NetraMark 2.0 platform launched a few weeks ago comes at just the right time. 90% of all clinical trials fail between drug development and market approval, with the most obvious example being the expensive Phase 3 trials, where up to 65% are discontinued.

    The young company has announced a milestone through a cooperation with Worldwide Clinical Trials (WCT). The NetraAI platform will be distributed through WCT's global network. Further partnerships exist with the National Institute of Mental Health (NIH) and a top-five pharmaceutical company. NetraMark is aiming for positive EBITDA by the end of the year. Thanks to the recently formed partnerships, the platform is expected to begin scaling up in the coming months. If the experienced management can implement this, the current market valuation will likely become obsolete.

    In a detailed interview, George Achilleos, CEO of NetraMark, explained the business model and discussed the company's goals and vision.

    In a detailed interview George Achilleos, CEO of NetraMark, explained the business model and discussed the Company's goals and vision with Lyndsay Malchuk.

    Siemens Energy - Makes a big splash

    Alongside booming defense stocks, Siemens Energy is one of the stocks of the moment on the German stock market. With the publication of its figures for the second quarter of 2025, the share price reached a new all-time high of EUR 65.58, despite a short-term correction due to the Trump shock.

    The Munich-based company increased its preliminary profit from EUR 501 million to EUR 615 million compared to the same period last year. Revenue rose from EUR 8.28 billion to EUR 9.96 billion in the same period.

    The significant increase in operating profit before special items, which more than quintupled to EUR 906 million, is particularly noteworthy. This results in an operating margin of 9.1%, well above the previous market expectations of 6.2%. In this context, the Company spoke of a "positive business development," without providing any specific details.

    In light of this development, Siemens Energy has raised its annual forecast. The Company now expects comparable revenue growth, adjusted for currency effects and portfolio changes, of 13 to 15%. The operating margin before special items is now expected to be between 4% and 6%, also above the previous target range of 3% to 5%.

    For the full year, Siemens Energy anticipates net income to rise to EUR 1 billion, a significant increase compared to the previous target, which was close to the break-even point. Free cash flow before taxes is expected to be around EUR 4 billion.


    Despite the uncertainties in the overall market, Siemens Energy reached a new all-time high with the publication of its quarterly figures. Taiwan Semiconductor also exceeded analyst estimates. NetraMark is likely to start scaling up thanks to the partnerships it has concluded.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by André Will-Laudien on November 7th, 2025 | 07:50 CET

    Fact check: After the correction comes the next rally! Ups and downs for Almonty, Aixtron, and Deutsche Pfandbriefbank

    • Mining
    • Tungsten
    • Banking
    • semiconductor
    • Technology

    Zigzag! Buy, sell, buy again! What wild volatility we are seeing on the trading board! Palantir delivers dream numbers, exceeding analysts' estimates by 10%, only to drop 20% after a brief rally. Traders have a saying for this: "Buy the rumor, sell the fact." Indeed, this kind of market behavior is often seen around earnings releases. In the case of Almonty, the stock surged an explosive 700% in just eight months, only to lose 40% in the subsequent correction. For flexible investors, it is worth taking a closer look and not losing sight of the fundamentals. Here are a few ideas for rocking the boat or tucking stocks away à la Kostolany!

    Read

    Commented by Armin Schulz on November 7th, 2025 | 07:05 CET

    BYD and Graphano Energy are driving the energy storage revolution - even Nordex is benefiting indirectly

    • Mining
    • graphite
    • Batteries
    • BatteryMetals
    • renewableenergies
    • Energy
    • Electromobility

    The energy landscape is undergoing radical change. The key no longer lies solely in the generation of green electricity, but in its intelligent storage and use. Electric vehicles are mutating into rolling power tanks that can stabilize grids, while extensive stationary storage facilities compensate for the fluctuating feed-in from wind and solar power. This revolution opens up massive savings potential for consumers and reduces the need for expensive grid upgrades. We take a look at whether BYD, Graphano Energy, and Nordex can benefit from this booming ecosystem.

    Read

    Commented by Fabian Lorenz on November 7th, 2025 | 07:00 CET

    Takeover battle between Novo Nordisk and Pfizer! Is BioNxt Solutions the next target?

    • Biotechnology
    • Biotech
    • Pharma
    • Innovations

    Who will acquire Metsera? That is currently the subject of dispute between Novo Nordisk and Pfizer. Both pharma giants are seeking access to a new generation of metabolic therapies through the acquisition - treatments that have the potential to transform the billion-dollar market for obesity and diabetes care. Novo Nordisk views Metsera's drug pipeline as a complement to its GLP-1-based preparations, while Pfizer is trying to finally gain a foothold in the market after several setbacks. The takeover battle illustrates that big pharma companies are willing to dig deep into their pockets for innovations. This makes BioNxt Solutions a potential takeover candidate. The Company is not only working on innovations in the field of multiple sclerosis and obesity, but on an entire platform technology.

    Read